Apricity Therapeutics Overview

  • Founded
  • 2012

  • Status
  • Private

  • Employees
  • 2

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $168K

  • Investors
  • 4

Apricity Therapeutics General Information


Developer of exploit solute carrier transporter platform for pushing chemotherapy agents directly to tumors intended to treat pediatric cancers. The company is building a solute carrier transporter platform to improve drug pharmacological effects, reduce drug toxicity, and target transporters that can be inhibited to treat human diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 953 Indiana Street
  • San Francisco, CA 94107
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Apricity Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Grant 01-Jan-2020 $168K Completed Startup
7. Grant 01-Jan-2019 00000 Completed Startup
6. Grant 01-Jan-2017 00000 Completed Startup
5. Grant 01-Jan-2016 00000 Completed Startup
4. Grant 01-Jan-2014 00000 Completed Startup
3. Grant 01-Jan-2012 00000 Completed Startup
2. Accelerator/Incubator 19-Sep-2012 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Apricity Therapeutics’s complete valuation and funding history, request access »

Apricity Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Kathleen Giacomini Ph.D Co-Founder & Scientific Advisor
You’re viewing 1 of 3 executive team members. Get the full list »

Apricity Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Apricity Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
QB3 Accelerator/Incubator 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Johnson & Johnson Innovation - JLABS Accelerator/Incubator 000 0000 000000 0
To view Apricity Therapeutics’s complete investors history, request access »